PTEN and non-small cell lung carcinoma: Other EGFR-TKI resistant mechanisms, such as EMT, PTEN loss, and activation of IGF-1R, should be further investigated to determine their influence on PD-L1 expression on EGFR-TKIs resistant NSCLC.